Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Bladder Cancer

Free Subscription 11.03.2019 1 Acta Clin Belg 1 Am J Ther 1 Ann R Coll Surg Engl 2 Beijing Da Xue Xue Bao Yi Xue Ban 1 Biochem Soc Trans 1 Biosens Bioelectron 1 BMC Cancer 1 BMC Urol 2 Cancer 1 Cancer Chemother Pharmacol 1 Clin Cancer Res 1 Clin Genitourin Cancer 1 Eur J Nucl Med Mol Imaging 3 Eur Urol 1 Gene 1 Gynecol Obstet Fertil Senol 1 Hinyokika Kiyo 1 Int J Mol Sci 2 Int J Urol 2 Investig Clin Urol 1 J Endourol 1 J Exp Clin Cancer Res 2 J Urol 1 Metabolomics 1 Mol Cancer Ther 1 Mol Cell Endocrinol 1 Mol Ther Nucleic Acids 1 Oncotarget 1 Pathol Oncol Res 1 Talanta 1 Transl Oncol 1 Urol Int 2 Urol Oncol 4 World J Urol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Acta Clin Belg

1. CENCINI E, Fabbri A, Schiattone L, Gentili F, et al
   Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.
   Acta Clin Belg. 2018;73:408-412.
   PubMed     Text format     Abstract available
   
   

   
   Am J Ther

2. KONALA VM, Adapa S, Aronow WS
   Immunotherapy in Bladder Cancer.
   Am J Ther. 2019 Feb 28. doi: 10.1097/MJT.0000000000000934.
   PubMed     Text format     Abstract available
   
   

   
   Ann R Coll Surg Engl

3. PAI A, Mackie S, Watson G
   Novel use of air in laser ablation of bladder transitional cell carcinoma.
   Ann R Coll Surg Engl. 2019;101:227.
   PubMed     Text format    
   
   

   
   Beijing Da Xue Xue Bao Yi Xue Ban

4. TANG XG, Yan Y, Qiu M, Lu J, et al
   [Retrospective study of young bladder urothelial carcinoma from a single center within 16 years].
   Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:630-633.
   PubMed     Text format     Abstract available
   
   
5. QIN ZJ, Bi H, Ma LL, Huang Y, et al
   [A primary intestinal-derived adenocarcinoma in intestine bladder substitutes: a case report].
   Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:737-739.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Soc Trans

6. BARNES JL, Zubair M, John K, Poirier MC, et al
   Carcinogens and DNA damage.
   Biochem Soc Trans. 2018;46:1213-1224.
   PubMed     Text format     Abstract available
   
   

   
   Biosens Bioelectron

7. WANG J, Zhang J, Li T, Shen R, et al
   Strand displacement amplification-coupled dynamic light scattering method to detect urinary telomerase for non-invasive detection of bladder cancer.
   Biosens Bioelectron. 2019;131:143-148.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

8. LV S, Wang W, Wang H, Zhu Y, et al
   PPARgamma activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
   BMC Cancer. 2019;19:204.
   PubMed     Text format     Abstract available
   
   

   
   BMC Urol

9. TEMRAZ S, Haibe Y, Charafeddine M, Saifi O, et al
   The unveiling of a new risk factor associated with bladder cancer in Lebanon.
   BMC Urol. 2019;19:16.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

10. CHU AT, Holt SK, Wright JL, Ramos JD, et al
    Delays in radical cystectomy for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32048.
    PubMed     Text format     Abstract available
    
    
11. MASIC S, Smaldone MC
    Treatment delays for muscle-invasive bladder cancer.
    Cancer. 2019 Mar 6. doi: 10.1002/cncr.32047.
    PubMed     Text format    
    
    

    
    Cancer Chemother Pharmacol

12. ZHANG W, Shi L, Zhao Z, Du P, et al
    Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer.
    Cancer Chemother Pharmacol. 2019 Mar 8. pii: 10.1007/s00280-019-03800.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

13. VANTAKU V, Dong J, Ambati CR, Perera D, et al
    sMulti-omics integration analysis robustly predicts high-grade patient survival and identifies CPT1B effect on fatty acid metabolism in Bladder Cancer.
    Clin Cancer Res. 2019 Mar 7. pii: 1078-0432.CCR-18-1515.
    PubMed     Text format     Abstract available
    
    

    
    Clin Genitourin Cancer

14. GILD P, Nguyen DD, Fletcher SA, Cole AP, et al
    Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy.
    Clin Genitourin Cancer. 2019 Jan 29. pii: S1558-7673(19)30036.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Nucl Med Mol Imaging

15. GIRARD A, Rouanne M
    Comment on: Relationship between the expression of PD-1/PD-L1 and (18)F-FDG uptake in bladder cancer.
    Eur J Nucl Med Mol Imaging. 2019 Mar 1. pii: 10.1007/s00259-019-04296.
    PubMed     Text format    
    
    

    
    Eur Urol

16. MONTORSI F, Gandaglia G
    Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2.
    Eur Urol. 2019;75:e31.
    PubMed     Text format    
    
    
17. NARAYAN VM, Lim AH, Dinney CPN
    Re: Impact of Immune and Stromal Infiltration on Outcomes Following Bladder-sparing Trimodality Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30165.
    PubMed     Text format    
    
    
18. LI R, Spiess PE, Gilbert SM, Necchi A, et al
    Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2019 Mar 1. pii: S0302-2838(19)30174.
    PubMed     Text format     Abstract available
    
    

    
    Gene

19. SONG Y, Yang Y, Liu L, Liu X, et al
    Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
    Gene. 2019 Mar 5. pii: S0378-1119(19)30211-2. doi: 10.1016/j.gene.2019.
    PubMed     Text format     Abstract available
    
    

    
    Gynecol Obstet Fertil Senol

20. DENIZE J, Bugel H, Bou Nasr E, Delcourt C, et al
    
    Gynecol Obstet Fertil Senol. 2018;46.
    PubMed     Text format    
    
    

    
    Hinyokika Kiyo

21. SASAHARA T, Sasaki H, Yoshiyama Y, Kimura S, et al
    [A Case of Urachal Carcinoma Treated with Laparoscopic Resection of Urachal Remnants with Partial Cystectomy that was Difficult to Diagnose Preoperatively by Transurethral Biopsy].
    Hinyokika Kiyo. 2018;64:345-348.
    PubMed     Text format     Abstract available
    
    

    
    Int J Mol Sci

22. HUMAYUN-ZAKARIA N, Arnold R, Goel A, Ward D, et al
    Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available
    
    

    
    Int J Urol

23. LEE A, Lee HJ, Huang HH, Ho H, et al
    Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13913.
    PubMed     Text format     Abstract available
    
    
24. ZACHOS I
    Editorial Comment to Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the "very-low-risk" group based on tumor size.
    Int J Urol. 2019 Mar 4. doi: 10.1111/iju.13929.
    PubMed     Text format    
    
    

    
    Investig Clin Urol

25. KIM DK, Lee JY, Jung JH, Hah YS, et al
    Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials.
    Investig Clin Urol. 2019;60:64-74.
    PubMed     Text format     Abstract available
    
    
26. KIM BS, Tae BS, Ku JH, Kwak C, et al
    Rate and association of lower urinary tract infection with recurrence after transurethral resection of bladder tumor.
    Investig Clin Urol. 2018;59:10-17.
    PubMed     Text format     Abstract available
    
    

    
    J Endourol

27. GOK B, Atmaca AF, Canda AE, Asil E, et al
    Robotic radical cystectomy with intracorporeal Studer pouch formation for bladder cancer: Experience in 98 cases.
    J Endourol. 2019 Mar 6. doi: 10.1089/end.2019.0036.
    PubMed     Text format     Abstract available
    
    

    
    J Exp Clin Cancer Res

28. GAO R, Zhang N, Yang J, Zhu Y, et al
    Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-beta1 in bladder cancer cells.
    J Exp Clin Cancer Res. 2019;38:111.
    PubMed     Text format     Abstract available
    
    

    
    J Urol

29. LEO MC, Gilbert SM, Wendel CS, Krouse RS, et al
    Development of a goal elicitation measure to support bladder cancer patients' choice about urinary diversion.
    J Urol. 2019 Mar 5:101097JU0000000000000203. doi: 10.1097/JU.0000000000000203.
    PubMed     Text format     Abstract available
    
    
30. WINTERS BR, Wen L, Holt SK, Dash A, et al
    Does the diagnosis of bladder cancer lead to higher rates of smoking cessation? Findings from the Medicare Health Outcomes Survey.
    J Urol. 2019 Mar 5:101097JU0000000000000206. doi: 10.1097/JU.0000000000000206.
    PubMed     Text format     Abstract available
    
    

    
    Metabolomics

31. RODRIGUES D, Pinto J, Araujo AM, Monteiro-Reis S, et al
    Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Metabolomics. 2018;14:62.
    PubMed     Text format     Abstract available
    
    

    
    Mol Cancer Ther

32. BERNDT-PAETZ M, Schulze P, Stenglein PC, Weimann A, et al
    Reduction of muscle-invasive tumors by photodynamic therapy with Tetrahydroporphyrin-Tetratosylat in an orthotopic rat bladder cancer model.
    Mol Cancer Ther. 2019 Mar 1. pii: 1535-7163.MCT-18-1194.
    PubMed     Text format     Abstract available
    
    

    
    Mol Cell Endocrinol

33. INOUE S, Mizushima T, Miyamoto H
    Role of the androgen receptor in urothelial cancer.
    Mol Cell Endocrinol. 2018;465:73-81.
    PubMed     Text format     Abstract available
    
    

    
    Mol Ther Nucleic Acids

34. HUANG C, Liao X, Jin H, Xie F, et al
    MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion.
    Mol Ther Nucleic Acids. 2019;16:51-62.
    PubMed     Text format     Abstract available
    
    

    
    Oncotarget

35. HOU T, Zhou L, Wang L, Kazobinka G, et al
    Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway.
    Oncotarget. 2019;10:1010.
    PubMed     Text format     Abstract available
    
    

    
    Pathol Oncol Res

36. SAWICKA E, Kratz EM, Szymanska B, Guzik A, et al
    Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer.
    Pathol Oncol Res. 2019 Mar 4. pii: 10.1007/s12253-019-00620.
    PubMed     Text format     Abstract available
    
    

    
    Talanta

37. MA Y, Mao G, Zhong Y, Wu G, et al
    Highly sensitive ratiometric fluorescent paper sensor for the urine assay of cancer.
    Talanta. 2019;194:199-204.
    PubMed     Text format     Abstract available
    
    

    
    Transl Oncol

38. OKUBO K, Isono M, Asano T, Sato A, et al
    Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase.
    Transl Oncol. 2019;12:669-682.
    PubMed     Text format     Abstract available
    
    

    
    Urol Int

39. CARRION A, Diaz F, Raventos C, Lozano F, et al
    Comparison of Outcomes between Standard and Palliative Management for High Grade Non-Muscle Invasive Bladder Cancer in Patients Older than 85 Years.
    Urol Int. 2019 Mar 7:1-7. doi: 10.1159/000496802.
    PubMed     Text format     Abstract available
    
    

    
    Urol Oncol

40. MITRA AP, Fairey AS, Skinner EC, Boorjian SA, et al
    Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
    Urol Oncol. 2019;37:48-56.
    PubMed     Text format     Abstract available
    
    
41. LINDNER AK, Klatte T, Comperat E, Heidegger I, et al
    Therapeutic rationale of targeting BCG and immune checkpoints in non-muscle-invasive bladder cancer: Is this the Future?
    Urol Oncol. 2019 Feb 27. pii: S1078-1439(19)30054.
    PubMed     Text format    
    
    

    
    World J Urol

42. FAN J, Wu K, Zhang P, He D, et al
    Green-laser assisted laparoscopic partial cystectomy for selective muscle-invasive bladder cancer: technique and initial outcome.
    World J Urol. 2019 Mar 6. pii: 10.1007/s00345-019-02712.
    PubMed     Text format     Abstract available
    
    
43. AKHTAR S, Al-Shammari A, Al-Abkal J
    Chronic urinary tract infection and bladder carcinoma risk: a meta-analysis of case-control and cohort studies.
    World J Urol. 2018 Feb 5. pii: 10.1007/s00345-018-2206.
    PubMed     Text format     Abstract available
    
    
44. LIANG H, Yang T, Wu K, He D, et al
    En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer.
    World J Urol. 2019 Mar 4. pii: 10.1007/s00345-019-02672.
    PubMed     Text format     Abstract available
    
    
45. BABJUK M
    En-bloc resection of non-muscle invasive bladder cancer: what must be answered in the future?
    World J Urol. 2019 Mar 5. pii: 10.1007/s00345-019-02710.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: